Biora prices $6M registered direct offering of 5.45M shares at $1.10; warrants also issued

BIORA THERAPEUTICS, INC.

Gross proceeds of ~$6M from sale of 5,454,548 shares at $1.10 per share.
Issued warrants to purchase 5,454,548 shares at $1.10; exercisable after stockholder approval.
Amended existing warrants to lower exercise price to $1.10 and extend term to 5 years post-approval.
Entered voting agreements with Athyrium and officers/directors to support stockholder approval.
Expected closing on April 3, 2024; H.C. Wainwright acted as placement agent.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BIORA THERAPEUTICS, INC. entered into Purchase Agreement with certain institutional and accredited investors valued at approximately $6 million (effective 2024-03-31).

Action: entry
Agreement: equity purchase
Counterparty: certain institutional and accredited investors
Value: approximately $6 million
Effective: 2024-03-31

Exact text from the filing

On March 31, 2024, Biora Therapeutics, Inc. (the “Company”) entered into a securities purchase agreement with certain institutional and accredited investors (the “Purchase Agreement”)

View on SEC.gov

380 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0001193125-24-084852

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.